Risk Assessment Tools for Identifying Individuals at Risk of Developing Type 2 Diabetes

Trials have demonstrated the preventability of type 2 diabetes through lifestyle modifications or drugs in people with impaired glucose tolerance. However, alternative ways of identifying people at risk of developing diabetes are required. Multivariate risk scores have been developed for this purpose. This article examines the evidence for performance of diabetes risk scores in adults by 1) systematically reviewing the literature on available scores and 2) their validation in external populations; and 3) exploring methodological issues surrounding the development, validation, and comparison of risk scores. Risk scores show overall good discriminatory ability in populations for whom they were developed. However, discriminatory performance is more heterogeneous and generally weaker in external populations, which suggests that risk scores may need to be validated within the population in which they are intended to be used. Whether risk scores enable accurate estimation of absolute risk remains unknown; thus, care is needed when using scores to communicate absolute diabetes risk to individuals. Several risk scores predict diabetes risk based on routine noninvasive measures or on data from questionnaires. Biochemical measures, in particular fasting plasma glucose, can improve prediction of such models. On the other hand, usefulness of genetic profiling currently appears limited.

[1]  A. Mainous,et al.  Assessing Risk for Development of Diabetes in Young Adults , 2007, The Annals of Family Medicine.

[2]  H. Bang,et al.  A patient self-assessment diabetes screening score:: development, validation, and comparison to other diabetes risk assessment scores , 2009 .

[3]  N J Wareham,et al.  The effect of varying the screening interval on false positives and duration of undiagnosed disease in a screening programme for type 2 diabetes , 2000, Journal of medical screening.

[4]  N. Wareham,et al.  Estimating the population impact of screening strategies for identifying and treating people at high risk of cardiovascular disease: modelling study , 2010, BMJ : British Medical Journal.

[5]  Bo Zhang,et al.  The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study , 2008, The Lancet.

[6]  Ac Pereira,et al.  TCF7L2 variant genotypes and type 2 diabetes risk in Brazil: significant association, but not a significant tool for risk stratification in the general population , 2008, BMC Medical Genetics.

[7]  Ken Williams,et al.  Validation of Prediction of Diabetes by the Archimedes Model and Comparison With Other Predicting Models , 2008, Diabetes Care.

[8]  Shumei S. Sun,et al.  Predictive ability of childhood metabolic components for adult metabolic syndrome and type 2 diabetes. , 2009, The Journal of pediatrics.

[9]  M. Rodríguez-Moran,et al.  Assessing progression to impaired glucose tolerance and type 2 diabetes mellitus , 2006, European journal of clinical investigation.

[10]  Robert L Hanson,et al.  Do measures of body fat distribution provide information on the risk of type 2 diabetes in addition to measures of general obesity? Comparison of anthropometric predictors of type 2 diabetes in Pima Indians. , 2003, Diabetes care.

[11]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[12]  F. Azizi,et al.  Impaired fasting glucose cutoff value of 5.6 mmol/l combined with other cardiovascular risk markers is a better predictor for incident Type 2 diabetes than the 6.1 mmol/l value: Tehran lipid and glucose study. , 2009, Diabetes research and clinical practice.

[13]  A. von Eckardstein,et al.  Risk for diabetes mellitus in middle-aged Caucasian male participants of the PROCAM study: implications for the definition of impaired fasting glucose by the American Diabetes Association. Prospective Cardiovascular Münster. , 2000, The Journal of clinical endocrinology and metabolism.

[14]  T. Welborn,et al.  The metabolic syndrome as a tool for predicting future diabetes: the AusDiab study , 2008, Journal of Internal Medicine.

[15]  S. Haffner,et al.  The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. , 2003, Diabetes care.

[16]  S. Bornstein,et al.  A Simplified Finnish Diabetes Risk Score to Predict Type 2 Diabetes Risk and Disease Evolution in a German Population , 2007, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[17]  N J Wareham,et al.  Do simple questions about diet and physical activity help to identify those at risk of Type 2 diabetes? , 2007, Diabetic medicine : a journal of the British Diabetic Association.

[18]  Relationship of Body Size and Shape to the Development of Diabetes in the Diabetes Prevention Program , 2006, Obesity.

[19]  B. Yawn,et al.  Screening for type 2 diabetes mellitus in adults: U.S. Preventive Services Task Force recommendation statement. , 2008, Annals of internal medicine.

[20]  B. Zinman,et al.  Adipokines and incident type 2 diabetes in an Aboriginal Canadian [corrected] population: the Sandy Lake Health and Diabetes Project. , 2008, Diabetes care.

[21]  R. DeFronzo,et al.  One-Hour Plasma Glucose Concentration and the Metabolic Syndrome Identify Subjects at High Risk for Future Type 2 Diabetes , 2008, Diabetes Care.

[22]  L. Groop,et al.  Genetic Prediction of Future Type 2 Diabetes , 2005, PLoS medicine.

[23]  Nancy R Cook,et al.  Advances in Measuring the Effect of Individual Predictors of Cardiovascular Risk: The Role of Reclassification Measures , 2009, Annals of Internal Medicine.

[24]  P. Savage,et al.  Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity. , 2004, Diabetes.

[25]  Heejung Bang,et al.  Identifying individuals at high risk for diabetes: The Atherosclerosis Risk in Communities study. , 2005, Diabetes care.

[26]  J. Shaw,et al.  Follow-up report on the diagnosis of diabetes mellitus. , 2003, Diabetes care.

[27]  B. Zinman,et al.  Metabolic syndrome and its components as predictors of incident type 2 diabetes mellitus in an Aboriginal community , 2009, Canadian Medical Association Journal.

[28]  A. Karter,et al.  Prediction of Type 2 Diabetes Mellitus With Alternative Definitions of the Metabolic Syndrome: The Insulin Resistance Atherosclerosis Study , 2005, Circulation.

[29]  N. Day,et al.  Fasting proinsulin concentrations predict the development of type 2 diabetes. , 1999, Diabetes care.

[30]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[31]  N. J. Wareham,et al.  Cardiovascular risk assessment scores for people with diabetes: a systematic review , 2009, Diabetologia.

[32]  B. Balkau,et al.  Reproducibility of the diagnosis of diabetes over a 30-month follow-up: the Paris Prospective Study. , 2001, Diabetes care.

[33]  K. Narayan,et al.  Clinical risk factors, DNA variants, and the development of type 2 diabetes. , 2009, The New England journal of medicine.

[34]  Richard W Morris,et al.  Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. , 2005, Archives of internal medicine.

[35]  S. Sharp,et al.  Evaluation of the Framingham risk score in the European Prospective Investigation of Cancer-Norfolk cohort: does adding glycated hemoglobin improve the prediction of coronary heart disease events? , 2008, Archives of internal medicine.

[36]  Anders Larsson,et al.  Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. , 2008, The New England journal of medicine.

[37]  Heiner Boeing,et al.  Use of Multiple Metabolic and Genetic Markers to Improve the Prediction of Type 2 Diabetes: the EPIC-Potsdam Study , 2009, Diabetes Care.

[38]  Shah Ebrahim,et al.  European guidelines on cardiovascular disease prevention in clinical practice , 2004 .

[39]  D. Marrero,et al.  Adapting the Diabetes Prevention Program Lifestyle Intervention for Delivery in the Community , 2007, The Diabetes educator.

[40]  A. Rissanen,et al.  Take Action to Prevent Diabetes – The IMAGE Toolkit for the Prevention of Type 2 Diabetes in Europe , 2010, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[41]  A. Zabetian,et al.  Waist/height ratio as a better predictor of type 2 diabetes compared to body mass index in Tehranian adult men--a 3.6-year prospective study. , 2006, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[42]  Ralph B D'Agostino,et al.  Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. , 2007, Archives of internal medicine.

[43]  Sirkka Keinänen-Kiukaanniemi,et al.  National type 2 diabetes prevention programme in Finland: FIN-D2D , 2007, International journal of circumpolar health.

[44]  V. Mohan,et al.  A simplified Indian Diabetes Risk Score for screening for undiagnosed diabetic subjects. , 2005, The Journal of the Association of Physicians of India.

[45]  J. Shaw,et al.  The metabolic syndrome as a predictor of incident diabetes mellitus in Mauritius , 2007, Diabetic medicine : a journal of the British Diabetic Association.

[46]  Jean Tichet,et al.  Predicting Diabetes: Clinical, Biological, and Genetic Approaches , 2008, Diabetes Care.

[47]  M. Laakso,et al.  Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial , 2002, The Lancet.

[48]  J. Boer,et al.  [Finnish questionnaire reasonably good predictor of the incidence of diabetes in The Netherlands]. , 2008, Nederlands tijdschrift voor geneeskunde.

[49]  J. Florez Clinical review: the genetics of type 2 diabetes: a realistic appraisal in 2008. , 2008, The Journal of clinical endocrinology and metabolism.

[50]  C. Ito,et al.  Prediction of diabetes mellitus (NIDDM). , 1996, Diabetes research and clinical practice.

[51]  J. Lindström,et al.  Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study , 2006, The Lancet.

[52]  E. Barrett-Connor,et al.  Strategies to identify adults at high risk for type 2 diabetes: the Diabetes Prevention Program. , 2005, Diabetes care.

[53]  C. Craig,et al.  Adiposity, physical fitness and incident diabetes: the physical activity longitudinal study , 2007, Diabetologia.

[54]  D. Atar,et al.  JOINT ESC GUIDELINES 2016 European Guidelines on cardiovascular disease prevention in clinical practice – Web Addenda , 2016 .

[55]  G. Nijpels,et al.  Finse vragenlijst redelijk goede voorspeller van het optreden van diabetes in Nederland , 2008 .

[56]  Mark I. McCarthy,et al.  Assessing the Combined Impact of 18 Common Genetic Variants of Modest Effect Sizes on Type 2 Diabetes Risk , 2008, Diabetes.

[57]  David W. Hosmer,et al.  Applied Logistic Regression , 1991 .

[58]  A. Cecile J.W. Janssens,et al.  Predicting Type 2 Diabetes Based on Polymorphisms From Genome-Wide Association Studies , 2008, Diabetes.

[59]  W. Herman Predicting Risk for Diabetes: Choosing (or Building) the Right Model , 2009, Annals of Internal Medicine.

[60]  M. Rutter,et al.  Use of Alternative Thresholds Defining Insulin Resistance to Predict Incident Type 2 Diabetes Mellitus and Cardiovascular Disease , 2008, Circulation.

[61]  L. Weinehall,et al.  A combination of HbA1c, fasting glucose and BMI is effective in screening for individuals at risk of future type 2 diabetes: OGTT is not needed , 2006, Journal of internal medicine.

[62]  Tianxi Cai,et al.  Joint Effects of Common Genetic Variants on the Risk for Type 2 Diabetes in U.S. Men and Women of European Ancestry , 2009, Annals of Internal Medicine.

[63]  Shah Ebrahim,et al.  Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) , 2007 .

[64]  L. Groop,et al.  Fasting Versus Postload Plasma Glucose Concentration and the Risk for Future Type 2 Diabetes , 2009, Diabetes Care.

[65]  J Tuomilehto,et al.  Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius? , 1999, Diabetes care.

[66]  N. Wareham,et al.  Diabetes risk score: towards earlier detection of Type 2 diabetes in general practice , 2000, Diabetes/metabolism research and reviews.

[67]  K. Narayan,et al.  A Two-Step Strategy for Identification of High-Risk Subjects for a Clinical Trial of Prevention of NIDDM , 1996, Diabetes Care.

[68]  M. Khoury,et al.  Public Health Genomics Approach to Type 2 Diabetes , 2008, Diabetes.

[69]  Kurt Hoffmann,et al.  An Accurate Risk Score Based on Anthropometric, Dietary, and Lifestyle Factors to Predict the Development of Type 2 Diabetes , 2007, Diabetes Care.

[70]  Ralph B D'Agostino,et al.  Prediction of type 2 diabetes using simple measures of insulin resistance: combined results from the San Antonio Heart Study, the Mexico City Diabetes Study, and the Insulin Resistance Atherosclerosis Study. , 2003, Diabetes.

[71]  Holly Janes,et al.  Assessing the Value of Risk Predictions by Using Risk Stratification Tables , 2008, Annals of Internal Medicine.

[72]  Walter C Willett,et al.  Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. , 2005, The American journal of clinical nutrition.

[73]  C. Berne,et al.  The Interaction between Impaired Acute Insulin Response and Insulin Resistance Predict Type 2 Diabetes and Impairment of Fasting Glucose , 2008, Upsala journal of medical sciences.

[74]  B. Rajendran Impaired fasting glucose versus impaired glucose tolerance. , 2001, The Journal of the Association of Physicians of India.

[75]  S. Fowler,et al.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002 .

[76]  J. Sundström,et al.  Use of multiple biomarkers to improve the prediction of death from cardiovascular causes , 2008 .

[77]  N. Cook Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve. , 2008, Clinical chemistry.

[78]  A. Ghasemi,et al.  The metabolic syndrome and incident diabetes: Assessment of alternative definitions of the metabolic syndrome in an Iranian urban population. , 2008, Diabetes research and clinical practice.

[79]  S. Zhan,et al.  An accurate risk score for estimation 5-year risk of type 2 diabetes based on a health screening population in Taiwan. , 2009, Diabetes research and clinical practice.

[80]  S. Haffner,et al.  Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? , 2004, Diabetes care.

[81]  Jaakko Tuomilehto,et al.  The diabetes risk score: a practical tool to predict type 2 diabetes risk. , 2003, Diabetes care.

[82]  M. Hanefeld,et al.  The Finnish Diabetes Risk Score is associated with insulin resistance and progression towards type 2 diabetes. , 2009, The Journal of clinical endocrinology and metabolism.

[83]  Raluca Mihaescu,et al.  Evaluation of risk prediction updates from commercial genome-wide scans , 2009, Genetics in Medicine.

[84]  Nicholas J Wareham,et al.  A simple risk score identifies individuals at high risk of developing Type 2 diabetes: a prospective cohort study. , 2008, Family practice.

[85]  F. Hu,et al.  A prediction model for type 2 diabetes risk among Chinese people , 2009, Diabetologia.

[86]  P. Whincup,et al.  Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease. , 2004, European heart journal.

[87]  T. Laatikainen,et al.  Prevention of type 2 diabetes in a primary health care setting. Interim results from the Greater Green Triangle (GGT) Diabetes Prevention Project. , 2007, Diabetes research and clinical practice.

[88]  Lynne E. Wagenknecht,et al.  Prediction of Type 2 Diabetes Using Alternate Anthropometric Measures in a Multi-Ethnic Cohort , 2009, Diabetes Care.

[89]  P. Macfarlane,et al.  Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies , 2008, The Lancet.

[90]  Hiroshi Kambe,et al.  Combined Measurement of Fasting Plasma Glucose and A1C Is Effective for the Prediction of Type 2 Diabetes , 2009, Diabetes Care.

[91]  C. Lau,et al.  Development of Diabetes in Chinese With the Metabolic Syndrome , 2007, Diabetes Care.

[92]  R. Hamman,et al.  Population screening for glucose intolerant subjects using decision tree analyses. , 1996, Diabetes research and clinical practice.

[93]  Mark Woodward,et al.  A Risk Score for Predicting Incident Diabetes in the Thai Population A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances. , 2006, Diabetes Care.

[94]  N. Pronk,et al.  Identifying individuals at risk for the development of type 2 diabetes mellitus. , 2003, The American journal of managed care.

[95]  Mark Walker,et al.  Combining Information from Common Type 2 Diabetes Risk Polymorphisms Improves Disease Prediction , 2006, PLoS medicine.

[96]  U. P. S. T. Force Screening for Type 2 Diabetes Mellitus in Adults: Recommendations and Rationale , 2003, Annals of Internal Medicine.

[97]  S. Haffner,et al.  Identification of Persons at High Risk for Type 2 Diabetes Mellitus: Do We Need the Oral Glucose Tolerance Test? , 2002, Annals of Internal Medicine.

[98]  R. D'Agostino,et al.  Genotype score in addition to common risk factors for prediction of type 2 diabetes. , 2008, The New England journal of medicine.

[99]  Edward J Boyko,et al.  Comparison of a clinical model, the oral glucose tolerance test, and fasting glucose for prediction of type 2 diabetes risk in Japanese Americans. , 2003, Diabetes care.

[100]  J. Shaw,et al.  Risk prediction models for the development of diabetes in Mauritian Indians , 2009, Diabetic medicine : a journal of the British Diabetic Association.

[101]  Henry Kahn,et al.  Two Risk-Scoring Systems for Predicting Incident Diabetes Mellitus in U.S. Adults Age 45 to 64 Years , 2009, Annals of Internal Medicine.

[102]  Ewout W Steyerberg,et al.  Predictive testing for complex diseases using multiple genes: Fact or fiction? , 2006, Genetics in Medicine.

[103]  G. Nichols,et al.  Validating the Framingham Offspring Study equations for predicting incident diabetes mellitus. , 2008, The American journal of managed care.

[104]  J. Mckenney,et al.  National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2002 .

[105]  Tamara Harris,et al.  Predicting the development of diabetes in older adults: the derivation and validation of a prediction rule. , 2005, Diabetes care.

[106]  Heejung Bang,et al.  Development and Validation of a Patient Self-assessment Score for Diabetes Risk , 2009, Annals of Internal Medicine.

[107]  Ewout W Steyerberg,et al.  The impact of genotype frequencies on the clinical validity of genomic profiling for predicting common chronic diseases , 2007, Genetics in Medicine.

[108]  R. Colagiuri,et al.  The status of national diabetes programmes: A global survey of IDF member associations. , 2010, Diabetes research and clinical practice.

[109]  M. Pencina,et al.  Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.

[110]  J. Pankow,et al.  Sensitivity and specificity of anthropometrics for the prediction of diabetes in a biracial cohort. , 2001, Obesity research.

[111]  S. Grundy,et al.  National Cholesterol Education Program Third Report of the National Cholesterol Education Program ( NCEP ) Expert Panel on Detection , Evaluation , and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III ) Final Report , 2022 .

[112]  M. Laakso,et al.  Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial , 2006, The Lancet.

[113]  Nancy R Cook,et al.  The Effect of Including C-Reactive Protein in Cardiovascular Risk Prediction Models for Women , 2006, Annals of Internal Medicine.

[114]  V. Mohan,et al.  Incidence of diabetes and pre-diabetes in a selected urban south Indian population (CUPS-19). , 2008, The Journal of the Association of Physicians of India.

[115]  J. Lindström,et al.  Tools for Predicting the Risk of Type 2 Diabetes in Daily Practice , 2008, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[116]  Russell Harris,et al.  Screening Adults for Type 2 Diabetes: A Review of the Evidence for the U.S. Preventive Services Task Force , 2003, Annals of Internal Medicine.

[117]  Torben Hansen,et al.  Development of a Type 2 Diabetes Risk Model From a Panel of Serum Biomarkers From the Inter99 Cohort , 2009, Diabetes Care.

[118]  A. Stadlmayr,et al.  A European Evidence-Based Guideline for the Prevention of Type 2 Diabetes , 2010, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[119]  S. Bornstein,et al.  Development of a Diabetes Prevention Management Program for Clinical Practice , 2007, Public health reports.

[120]  L. Niskanen,et al.  Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. , 2002, American journal of epidemiology.

[121]  Shah Ebrahim,et al.  European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) , 2012, International Journal of Behavioral Medicine.

[122]  M. Trevisan,et al.  Additional Contribution of Emerging Risk Factors to the Prediction of the Risk of Type 2 Diabetes: Evidence From the Western New York Study , 2008, Obesity.

[123]  E. Ding,et al.  Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. , 2009, JAMA.

[124]  Aziz Sheikh,et al.  Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore , 2009, BMJ : British Medical Journal.

[125]  Shah Ebrahim,et al.  Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts) , 2007 .

[126]  S. Bornstein,et al.  Validation of a simple clinical diabetes prediction model in a middle-aged, white, German population. , 2007, Archives of internal medicine.